Cochlear Limited operates in the Electromedical equipment sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cochlear Limited with three other
medical equipment manufacturers in Australasia:
Compumedics Limited
(2019
sales of 41.51 million Australian Dollars [US$28.84 million]
of which 45%
was Australia and Asia Pacific),
Nanosonics Limited
(84.32 million Australian Dollars [US$58.60 million]
of which 100%
was Biotechnology), and
Nova Eye Medical Ltd
(81.81 million Australian Dollars [US$56.85 million]
of which 80%
was Lasers & Ultrasounds).
Sales Analysis.
Cochlear Limited reported sales of A$1.43 billion (US$991.46 million)
for the
fiscal
year ending
June of 2019.
This
represents
an
increase of 4.6%
versus 2018, when the company's sales were A$1.36 billion.
Sales at Cochlear Limited have increased during each of the previous five years
(and since 2014, sales have increased a total of 77%).
Sales of Emea saw an increase
of
8.4% in 2019, from
A$478.90 million to A$519.20 million.